The growing demand for complex oncology drugs and medicines to treat a wide range of therapeutic areas has driven heightened levels of clinical development activity and changed the clinical trials landscape drastically. Ongoing technological development in the clinical trials space is also driving change in the way clinical trials are managed, and how the drug supply is developed, manufactured and packaged. Dave Wilson, head of operations at Sharp Clinical Services, explains why companies are increasingly seeking to automate processes in response to a demand
for improved productivity while maintaining high-quality results.

Comments are closed.

%d bloggers like this: